About Generate
Generate is a Healthcare company based in Los Angeles (United States) founded in 1977, and was acquired by The Cooper Companies in November 2021. It operates as a provider of services for the storage of stem cells. Generate has completed 3 acquisitions, including Cell Care, Cells For Life and Insception. Generate offers products and services including Sperm Donation Service, Egg Donation Service, Stem Cell Storage, and IVF Supplies. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository. Its legal entity is Generate Life Sciences Inc. Its competitors include StemCyte, China Cord Blood, Provia Labs, Forever Labs and Mill Creek Life Sciences and 1 more; 4 of its 6 listed competitors have raised funding.
Company details
The company was founded in 1977 in Los Angeles, United States, and operates in the biotechnology sector focused on reproductive and genetic health. A technology platform is utilized for stem cell storage, while sperm and ovum preservation services are also offered. Genetic screening test kits for children and IVF clinical software are provided to support medical applications in fertility and diagnostics.
- Headquarters Los Angeles, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website generate.com
- Social LinkedIn
- Acquired by The Cooper Companies (Nov 2021)
- Legal Name Generate Life Sciences Inc.
- Investors
- Investments & AcquisitionsCell Care
& 2 more
- Acquired byThe Cooper Companies
(Nov 2021)
Products & Services of Generate
Generate offers a comprehensive portfolio of products and services, including Sperm Donation Service, Egg Donation Service, Stem Cell Storage, and IVF Supplies.
Platform for selecting screened sperm donors for family building.
Program for matching and using egg donors in fertility treatments.
Service for preserving newborn stem cells for future medical use.
Provision of tools and software for IVF clinics and donor agencies.
Investors in Generate
Generate has secured backing from 1 investor. Prominent investors backing the company include The Cooper Companies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Optical correction devices and women's health products are developed. | 1958 | coopercos.com | Pleasanton, United States |
Investor details for Generate
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Generate
Generate has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cell Care, Cells For Life and Insception.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cord blood is collected and stored for biobanking purposes. | cellcare.com.au | Moorabbin, Australia | 2009 | Jun 2021 | •••• | |
Umbilical cord blood is stored and preserved in a biorepository. | cellsforlife.com | Markham, Canada | 1999 | Jun 2021 | •••• | |
Largest cord blood program in Canada | insception.com | Mississauga, Canada | 1996 | Jun 2021 | •••• |
Complete acquisition details for Generate
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Generate
5 dated milestones of Generate across 44 years, from founding to its latest funding, stage changes and deals.
- Founded Generate is founded.
- Acquisition Acquires Insception.
- Acquisition Acquires Cells For Life.
- Acquisition Acquires Cell Care.
- Exit Acquired by The Cooper Companies.
Competitors of Generate
Generate has 6 listed competitors in our database, 4 of them funded. They include StemCyte, China Cord Blood, Provia Labs, Forever Labs and Mill Creek Life Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| stemcyte.com | 1997 | Covina, United States | $23.25M | 43 | Umbilical cord blood stem cell transplantation and therapeutic products company | |
| globalcordbloodcorp.com | 2003 | Hong Kong, China | – | – | Biobanking services for umbilical cord blood stem cells are provided. | |
| provialabs.com | 2009 | Littleton, United States | $1M | 15 | Stem cell biobanking and manufacturing from children's teeth are provided. | |
| foreverlabs.com | 2015 | Detroit, United States | $2.22M | 9 | Stem cells are stored and preserved for future therapeutic applications. | |
| millcreekls.com | 2010 | Rochester, United States | $625,000 | – | Tools and technologies to support the development and application of cellular and biologic therapeutics | |
| lacell-usa.com | 2010 | New Orleans, United States | – | – | Stem Cell Production |
Detailed competitors of Generate
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Generate (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Generate
Complete news archive for Generate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Generate
Generate was founded in 1977.
Generate is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
The company was founded in 1977 in Los Angeles, United States, and operates in the biotechnology sector focused on reproductive and genetic health. A technology platform is utilized for stem cell storage, while sperm and ovum preservation services are also offered. Genetic screening test kits for children and IVF clinical software are provided to support medical applications in fertility and diagnostics.
Generate's top competitors include StemCyte, Forever Labs and China Cord Blood.
Generate offers Sperm Donation Service, Egg Donation Service, Stem Cell Storage, and IVF Supplies.
Generate has made 3 acquisitions, including Cell Care, Cells For Life, and Insception.
Generate has 1 investor. Key investors include The Cooper Companies.
Generate operates through Generate Life Sciences Inc..
Yes. Generate was acquired by The Cooper Companies in November 2021.